Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg

Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets are a combination medication used in HIV treatment. This oral tablet contains efavirenz, emtricitabine, and tenofovir disoproxil fumarate, manufactured by Teva Canada Limited.

Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets are commonly used as part of antiretroviral therapy (ART) to manage HIV infection. This combination medication helps control the virus, reducing its ability to replicate in the body. It is often prescribed to adults and adolescents as a part of a comprehensive treatment plan.

Common effects of Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets may include dizziness, nausea, and headache. Some individuals might experience fatigue or unusual dreams. These effects can vary from person to person and may subside as the body adjusts to the medication.

It is important to follow the advice of a healthcare provider when taking Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets. This medication should be stored at room temperature and kept out of reach of children. Regular monitoring and follow-up appointments are recommended to ensure the medication's effectiveness and safety.

Teva-Efavirenz/Emtricitabine/Tenofovir 300 mg tablets may interact with other medications, including certain antacids, antibiotics, and antifungal drugs. Alcohol consumption should be avoided as it can increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking.